Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Inovio Stock Is Crashing Today

TheMotleyFool

0 0

Shares of Inovio Pharmaceuticals (NASDAQ: INO) were crashing 32.5% lower as of 9:37 a.m. EDT on Monday. The huge decline came after the company announced that the U.S. Food and Drug Administration placed Inovio's filing to begin a phase 2/3 clinical study of COVID-19 vaccine candidate INO-4800 on partial clinical hold.

Investors are justifiably worried about the status of Inovio's COVID-19 vaccine program. The small biotech had hoped to start its phase 2/3 study of INO-4800 in September. That's now completely off the table.

Image source: Getty Images.

Source Fool.com

Like: 0

INO

Share